- Parties: The appellant was Apotex Inc. The respondents were Janssen Inc. and Pharmascience Inc.

- Subject Matter: This appeal sought to challenge a decision of Justice Southcott of the Federal Court dated February 14, 2023, under section 27 of the Patent Act. The matter involved interlocutory issues likely relating to patent litigation, with the appellant requesting an expedited hearing and filing various motion records, affidavits, and memoranda in support. The appeal was ultimately dismissed.

- Date: The appeal filed in February 2023 under section 27 of the Patent Act was officially dismissed by the Federal Court of Appeal on April 13, 2023. The dismissal appears final unless challenged further.

- Venue: This was a federal case before the Federal Court of Appeal.

- Amount: No financial award was specified.